Page 122 - வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA trims use of contentious Alzheimer s drug amid backlash MATTHEW PERRONE, AP Health Writer July 8, 2021 FacebookTwitterEmail FILE - This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Thursday, July 8, 2021, U.S. health regulators approved new prescribing instructions for the controversial Alzheimer s drug that are likely to limit use of the expensive therapy, which has faced an intense public backlash. (Biogen via AP, File)AP WASHINGTON (AP) A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use.

United statesSuzanne schindlerAaron kesselheimMichael yeeRonald petersenScience departmentWashington university in stMayo clinicWashington universityMatthew perroneAssociated press healthHoward hughes medical instituteஒன்றுபட்டது மாநிலங்களில்ஸுஸ்யாந் ஶிஂட்லர்மைக்கேல் யீரொனால்ட் பீட்டர்சன்